Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.11646/zootaxa.5005.2.11 | DOI Listing |
Zootaxa
December 2024
Ranong Marine Fisheries Research and Development Station; 157 Chaloem Phrakiat Rd.; Paknam; Muang; Ranong 85000; Thailand.
We redescribe the type material of Phyllodactylus siamensis Boulenger, 1899, type species of the Southeast Asian gekkonid genus Dixonius Bauer, Good & Branch, 1997, using external morphology and cranial osteology. There is some evidence that the type series contains more than one species; we hence designate a lectotype in order to stabilize nomenclature and provide more precision on the geographical location of the type locality. Because the current concept of Dixonius siamensis auctorum is incomplete and composite, we provide a revised diagnosis based on the presently designated lectotype and a paralectotype from the same locality, as well as observations on new material from the type locality and the first photographs of live topotypical individuals.
View Article and Find Full Text PDFPachyrhabda citrinacma Meyrick, 1936, an endemic species to Formosa (Taiwan), was named by Edward Meyrick based on two specimens collected by Syuti Issiki. Despite some newly discovered stathmopodids exhibiting characteristics matching the original description, the lack of information regarding the type specimen depository led to the species remaining elusive since its initial naming. In this study, we successfully rediscovered a P.
View Article and Find Full Text PDFPeerJ
September 2024
Department of Geosciences and Geography, University of Helsinki, Helsinki, Finland.
The endangered hispid hare () is one of the least studied mammal species. The recent rediscovery of hispid hare in Chitwan National Park (CNP) after three decades, necessitated urgent conservation measures. A detailed investigation into the species' ecology is imperative for developing evidence-based conservation strategies to support these efforts.
View Article and Find Full Text PDFClin Cancer Res
October 2024
Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Purpose: The treatment efficacy of nivolumab was evaluated in patients with advanced, treatment-refractory solid mismatch repair deficiency/microsatellite-instable (dMMR/MSI) tumors, and in-depth biomarker analyses were performed to inform precision immunotherapy approaches.
Patients And Methods: Patients with dMMR/MSI tumors who exhausted standard-of-care treatment options were enrolled in the Drug Rediscovery Protocol, a pan-cancer clinical trial that treats patients with cancer based on their tumor molecular profile with off-label anticancer drugs (NCT02925234). Patients received nivolumab (four cycles of 240 mg every 2 weeks, thereafter 480 mg every 4 weeks).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!